loperamide and scopolamine hydrobromide

loperamide has been researched along with scopolamine hydrobromide in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Mearin, F	1
Brookes, SSJ; Costa, M; Dinning, PG; Heitmann, PT; Keightley, L; Spencer, NJ; Wattchow, DA; Wiklendt, L	1

Reviews

2 review(s) available for loperamide and scopolamine hydrobromide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Drug treatment of irritable bowel syndrome: an unmet need]. Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:3 Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine	2007

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

[Drug treatment of irritable bowel syndrome: an unmet need].

Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:3

Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine

2007

Other Studies

3 other study(ies) available for loperamide and scopolamine hydrobromide

Article	Year
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs. Journal of medicinal chemistry, 1985, Volume: 28, Issue:3 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium	1985
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
The effects of loperamide on excitatory and inhibitory neuromuscular function in the human colon. Neurogastroenterology and motility, 2022, Volume: 34, Issue:11 Topics: Animals; Colon; Electric Stimulation; Gastrointestinal Motility; Humans; Loperamide; Muscle Contraction; Naloxone; Nitroarginine; Scopolamine	2022